logo

Akers Biosciences, Inc. (AKER)



Trade AKER now with
  Date
  Headline
7/7/2020 9:09:50 AM Akers, Partner Premas Biotech Initiate Animal Studies For SARS-CoV-2 Vaccine Candidate In India
4/6/2020 9:29:47 AM Akers, Premas Biotech Report Progress In Vaccine Development For Covid-19
12/11/2019 9:43:57 AM Akers BioSciences Regains Compliance With Nasdaq Listing Standards
12/5/2019 9:52:28 AM Akers Biosciences Prices Public Offering Of 1.99 Mln Units At $4.00/unit
12/5/2019 8:55:41 AM Akers Biosciences To Continue Its Strategic Review; Establishes Advisory Board
11/22/2019 9:20:18 AM Akers Biosciences Plans One-for-Twenty Four Reverse Stock Split
11/15/2018 7:08:36 AM Akers Biosciences Q3 Net Loss Attributable To Shareholders $3.08 Mln; Total Revenue $0.56 Mln
11/7/2018 9:17:41 AM Akers Biosciences Intends To Explore Strategic Alternatives; Plans 1:8 Reverse Stock Split
7/18/2018 7:04:36 AM Akers Biosciences Signs A Further Independent Sales Representative Organization For Heparin PF4 Rapid Test
6/29/2018 7:05:09 AM Akers Biosciences Requests Temporary Suspension Of Trading On London Stock Exchange
5/29/2018 7:04:46 AM Akers Biosciences Withdraws FDA 510(k) Submission For PIFA Chlamydia Rapid Assay Pending Further Evaluation
4/12/2018 7:12:47 AM Akers Biosciences Expands Outsourced US Distribution Capabilities For Heparin PF4 Rapid Test
4/3/2018 7:14:25 AM Akers Biosciences 2017 Total Revenue Up 33% To $3.93 Mln
3/26/2018 7:03:25 AM Akers Biosciences Signs US Distribution Agreement With Diagnostica Stago